Holen Sie sich die Stockscreener-App
0.26
0.76%
-0.002
IGC Pharma Inc Aktie (IGC) Neueste Nachrichten
IGC Pharma, New to The Street launch 12-part national media partnership - Yahoo Finance
New to The Street and IGC Pharma (NYSE American:IGC) Launch Strategic 12-Part National Media Partnership to Accelerate Investor Awareness and Market Positioning - The Daily Corinthian
Macro Review: Is IGC Pharma Inc likely to announce a buybackChart Signals & Verified Swing Trading Watchlists - baoquankhu1.vn
If You Invested $1,000 in IGC Pharma Inc (IGC) - Stock Titan
Growth Report: Does IGC Pharma Inc stock benefit from AI growthEntry Point & Technical Pattern Based Signals - baoquankhu1.vn
Ascendiant Capital maintains IGC Pharma (IGC) buy recommendation - MSN
Fund Flows: Can IGC Pharma Inc ride the EV wave2026 PreEarnings & Daily Technical Stock Forecast Reports - baoquankhu1.vn
India Globalization Capital, Inc.: Fundamental Analysis and Financial Ratings | IGC | US45408X3089 - marketscreener.com
IGC Pharma earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
IGC Pharma Reports Financial Results and Clinical Progress for the Period Ended December 31, 2025 - Hastings Tribune
IGC Achieves Major Milestone in Alzheimer's Trial Amid Financial Loss - GuruFocus
IGC Pharma’s AI-Driven Innovations and Patent Portfolio for Alzheimer’s Disease and Neuropsychiatric Treatments - Minichart
IGC to Showcase AI Platform for Alzheimer's Research at 2026 Con - GuruFocus
IGC Pharma : Annual Transition Report (Form 10-KT) - marketscreener.com
IGC Pharma (IGC) Transition 10-KT: CALMA Phase 2 shows interim agitation improvements - Stock Titan
IGC Pharma to Showcase AI Platform with Alzheimer’s Disease Data Initiative at ADPD 2026 - BioSpace
IGC Pharma to Showcase AI Platform with Alzheimer's Disease Data Initiative at ADPD 2026 - PharmiWeb.com
IGC Pharma to Showcase AI Platform With Alzheimer's Disease Data Initiative at ADPD 2026 - 富途牛牛
CEO Change: What is the Moat Score of IGC Pharma IncMarket Activity Recap & Real-Time Volume Analysis Alerts - baoquankhu1.vn
IGC Pharma (NYSEAMERICAN:IGC) Stock Price Down 1.2% – Time to Sell? - Defense World
IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial - Nasdaq
IGC Pharma Secures New Debt Financing for Liquidity - The Globe and Mail
IGC Pharma Secures ~$526K in Financing, Including Default-Convertible Note With Vanquish - TradingView
IGC Pharma (NYSE: IGC) raises cash via discounted note and $219,000 loan - Stock Titan
How IGC Pharma Inc. stock compares to growth peersDollar Strength & Smart Money Movement Tracker - Naître et grandir
EPS Watch: Should value investors consider IGC Pharma IncJuly 2025 Setups & Fast Momentum Entry Tips - baoquankhu1.vn
IGC Pharma, Inc. announced that it has received $0.307 million in funding - marketscreener.com
IGC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
IGC Should I Buy - Intellectia AI
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Suppo - PharmiWeb.com
IGC Pharma Files Utility Patent Applications Covering AI-Based Data Harmonization Architecture Supporting Alzheimer's Research - Nasdaq
IGC PE Ratio & Valuation, Is IGC Overvalued - Intellectia AI
FOMO Trade: What is the Moat Score of IGC Pharma IncBond Market & Verified Momentum Stock Ideas - baoquankhu1.vn
Trend Report: What is the Moat Score of IGC Pharma IncJuly 2025 Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn
IGC Pharma Notes Updated Research Coverage from Ascendiant Capital Markets - The Globe and Mail
Aug Final Week: Is IGC Pharma Inc a cyclical or defensive stockWatch List & Real-Time Sentiment Analysis - baoquankhu1.vn
IGC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
IGC Pharma expands Phase 2 CALMA trial with new clinical site - Yahoo Finance
IGC Enhances Alzheimer's Trial with New Clinical Research Collab - GuruFocus
Miami neurology network joins Alzheimer’s agitation drug trial - Stock Titan
Will IGC Pharma Inc. stock go up in YEARDay Trade & Daily Momentum Trading Reports - mfd.ru
Trend Review: Will IGC Pharma Inc benefit from green energy policiesJuly 2025 PreEarnings & Weekly Watchlist of Top Performers - baoquankhu1.vn
IGC: CALMA trial nears completion and MINT-AD AI platform set for beta launch amid favorable regulations - TradingView
IGC: Alzheimer's drug trial nears completion as AI dementia tool readies for beta launch - TradingView
Is IGC Pharma Inc. stock a buy before product launchesJuly 2025 Movers & Long Hold Capital Preservation Tips - mfd.ru
IGC Pharma Secures North American Composition Protection for IGC-AD1 as Phase 2 CALMA Enrollment Advances - GuruFocus
Low-dose THC Alzheimer’s drug from IGC wins key North America patent - Stock Titan
IGC Pharma to Participate in Fireside Chat With Ascendiant Capital Markets - Finviz
Is IGC Pharma Inc. likely to announce a buybackJuly 2025 Market Mood & Daily Entry Point Alerts - mfd.ru
Aug Catalysts: Should I trade or invest in IGC Pharma IncJuly 2025 Intraday Action & Stepwise Swing Trade Plans - baoquankhu1.vn
Why IGC Pharma Inc. (IGS1) stock could rally stronglyJuly 2025 Breakouts & Accurate Entry and Exit Point Alerts - mfd.ru
0.99%
3.03%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):